Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning

Jan 1, 2025·
Jie Luo
,
Muge Molbay
,
Ying Chen
,
Izabela Horvath
,
Karoline Kadletz
,
Benjamin Kick
Shan Zhao
Shan Zhao
,
Rami Al-Maskari
,
Inderjeet Singh
,
Mayar Ali
,
Harsharan Singh Bhatia
,
David-Paul Minde
,
Moritz Negwer
,
Luciano Hoeher
,
Gian Marco Calandra
,
Bernhard Groschup
,
Jinpeng Su
,
Ceren Kimna
,
Zhouyi Rong
,
Nikolas Galensowske
,
Mihail Ivilinov Todorov
,
Denise Jeridi
,
Tzu-Lun Ohn
,
Stefan Roth
,
Alba Simats
,
Vikramjeet Singh
,
Igor Khalin
,
Chenchen Pan
,
Bernardo A. Arús
,
Oliver T. Bruns
,
Reinhard Zeidler
,
Arthur Liesz
,
Ulrike Protzer
,
Nikolaus Plesnila
,
Siegfried Ussar
,
Farida Hellal
,
Johannes Paetzold
,
Markus Elsner
,
Hendrik Dietz
,
Ali Erturk
· 0 min read
Abstract
Abstract Efficient and accurate nanocarrier development for targeted drug delivery is hindered by a lack of methods to analyze its cell-level biodistribution across whole organisms. Here we present Single Cell Precision Nanocarrier Identification (SCP-Nano), an integrated experimental and deep learning pipeline to comprehensively quantify the targeting of nanocarriers throughout the whole mouse body at single-cell resolution. SCP-Nano reveals the tissue distribution patterns of lipid nanoparticles (LNPs) after different injection routes at doses as low as 0.0005 mg kg −1 —far below the detection limits of conventional whole body imaging techniques. We demonstrate that intramuscularly injected LNPs carrying SARS-CoV-2 spike mRNA reach heart tissue, leading to proteome changes, suggesting immune activation and blood vessel damage. SCP-Nano generalizes to various types of nanocarriers, including liposomes, polyplexes, DNA origami and adeno-associated viruses (AAVs), revealing that an AAV2 variant transduces adipocytes throughout the body. SCP-Nano enables comprehensive three-dimensional mapping of nanocarrier distribution throughout mouse bodies with high sensitivity and should accelerate the development of precise and safe nanocarrier-based therapeutics.
Type
Publication
Nature Biotechnology